Diferencia entre revisiones de «Neuromuscular blocking agents»
Sin resumen de edición |
(→Types) |
||
| (No se muestra una edición intermedia de otro usuario) | |||
| Línea 14: | Línea 14: | ||
!Side effects | !Side effects | ||
|- | |- | ||
| ''' | | '''Depolarizing''' | ||
|- | |- | ||
|[[Succinylcholine]] | |[[Succinylcholine]] | ||
| Línea 21: | Línea 21: | ||
|fasciculations, post-operative pain | |fasciculations, post-operative pain | ||
|- | |- | ||
| '''Depolarizing''' | | '''Non-Depolarizing''' | ||
|- | |- | ||
|[[Vecuronium]] (Norcuron) | |[[Vecuronium]] (Norcuron) | ||
| Línea 49: | Línea 49: | ||
[[Category:Pharmacology]] | [[Category:Pharmacology]] | ||
[[Category:Critical Care]] | |||
Revisión actual - 00:47 25 feb 2020
Background
- Non-depolarizing
- Competitively block binding of ACh to its receptors
- Depolarizing
- Depolarizing skeletal muscle fiber
- Persistent depolarization makes the muscle fiber resistant to further stimulation by ACh
Types
| Agent | Time to onset (seconds) | Duration (minutes) | Side effects |
|---|---|---|---|
| Depolarizing | |||
| Succinylcholine | fasciculations, post-operative pain | ||
| Non-Depolarizing | |||
| Vecuronium (Norcuron) | 60 | 30–40 | Few, may cause prolonged paralysis and promote muscarinic block |
| Rocuronium (Zemuron) | 75 | 45–70 | may promote muscarinic block |
| Pancuronium (Pavulon) | 90 | 180 or more |
|
See Also
- Reversal agent: Sugammadex